Discovery of a Potent, Orally Active, and Long-Lasting P2X7 Receptor Antagonist as a Preclinical Candidate for Delaying the Progression of Chronic Kidney Disease.
Zhang R, Su K, Yang L, Duan H, Tang L, Tang M, Zhao M, Ye N, Cai X, Jiang X, Li N, Peng J, Zhang X, Tang L, Qiu Q, Chen L, Wu W, Hu J, Ma L, Ye H.
Zhang R, et al. Among authors: duan h.
J Med Chem. 2024 Sep 23. doi: 10.1021/acs.jmedchem.4c01395. Online ahead of print.
J Med Chem. 2024.
PMID: 39311818